Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
Day One Biopharmaceuticals, Inc.
Ikena Oncology
Day One Biopharmaceuticals, Inc.
ABM Therapeutics Corporation
Cambridge University Hospitals NHS Foundation Trust
Tocagen Inc.
CureOne
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins